| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,086 |
2,909 |
$266K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,479 |
7,002 |
$230K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
5,172 |
3,845 |
$101K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
703 |
703 |
$57K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
5,235 |
5,180 |
$54K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
826 |
826 |
$53K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
585 |
573 |
$47K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
5,603 |
5,563 |
$46K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
693 |
680 |
$34K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
409 |
406 |
$33K |
| 90834 |
Psychotherapy, 45 minutes with patient |
304 |
214 |
$31K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
333 |
333 |
$19K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
562 |
553 |
$16K |
| 87634 |
|
232 |
226 |
$14K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
236 |
222 |
$11K |
| 90461 |
|
870 |
866 |
$5K |
| 87430 |
|
394 |
384 |
$5K |
| 94760 |
|
1,464 |
1,369 |
$3K |
| 96127 |
|
350 |
350 |
$3K |
| 90785 |
|
207 |
184 |
$3K |
| 99050 |
|
179 |
177 |
$2K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
14 |
14 |
$2K |
| 99188 |
|
55 |
55 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
44 |
42 |
$529.90 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
13 |
13 |
$281.52 |
| 85018 |
|
79 |
79 |
$184.42 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$174.96 |
| 99177 |
|
26 |
26 |
$88.46 |
| 83655 |
|
39 |
39 |
$62.45 |
| 90633 |
|
63 |
63 |
$0.00 |
| 99072 |
|
458 |
400 |
$0.00 |
| 90670 |
|
150 |
149 |
$0.00 |
| 90648 |
|
126 |
125 |
$0.00 |
| 90661 |
|
178 |
170 |
$0.00 |
| 96160 |
|
66 |
66 |
$0.00 |
| 90686 |
|
857 |
854 |
$0.00 |
| 90723 |
|
68 |
67 |
$0.00 |
| 90680 |
|
56 |
55 |
$0.00 |
| 36416 |
|
45 |
43 |
$0.00 |
| 90677 |
|
12 |
12 |
$0.00 |